1. Home
  2. NTLA vs DEC Comparison

NTLA vs DEC Comparison

Compare NTLA & DEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTLA
  • DEC
  • Stock Information
  • Founded
  • NTLA 2014
  • DEC 2001
  • Country
  • NTLA United States
  • DEC United States
  • Employees
  • NTLA N/A
  • DEC N/A
  • Industry
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • DEC
  • Sector
  • NTLA Health Care
  • DEC
  • Exchange
  • NTLA Nasdaq
  • DEC Nasdaq
  • Market Cap
  • NTLA 1.2B
  • DEC 1.2B
  • IPO Year
  • NTLA 2016
  • DEC N/A
  • Fundamental
  • Price
  • NTLA $16.11
  • DEC $14.25
  • Analyst Decision
  • NTLA Buy
  • DEC Strong Buy
  • Analyst Count
  • NTLA 20
  • DEC 4
  • Target Price
  • NTLA $32.30
  • DEC $22.25
  • AVG Volume (30 Days)
  • NTLA 4.8M
  • DEC 468.6K
  • Earning Date
  • NTLA 11-06-2025
  • DEC 01-01-0001
  • Dividend Yield
  • NTLA N/A
  • DEC 5.69%
  • EPS Growth
  • NTLA N/A
  • DEC N/A
  • EPS
  • NTLA N/A
  • DEC N/A
  • Revenue
  • NTLA $52,857,000.00
  • DEC $1,148,432,000.00
  • Revenue This Year
  • NTLA $8.90
  • DEC $128.52
  • Revenue Next Year
  • NTLA N/A
  • DEC $0.46
  • P/E Ratio
  • NTLA N/A
  • DEC N/A
  • Revenue Growth
  • NTLA 14.99
  • DEC 64.19
  • 52 Week Low
  • NTLA $5.90
  • DEC $10.08
  • 52 Week High
  • NTLA $23.76
  • DEC $17.70
  • Technical
  • Relative Strength Index (RSI)
  • NTLA 81.73
  • DEC 37.60
  • Support Level
  • NTLA $10.89
  • DEC $13.89
  • Resistance Level
  • NTLA $12.03
  • DEC $15.89
  • Average True Range (ATR)
  • NTLA 0.93
  • DEC 0.38
  • MACD
  • NTLA 0.34
  • DEC -0.20
  • Stochastic Oscillator
  • NTLA 95.09
  • DEC 13.79

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

About DEC Diversified Energy Company plc

Diversified Energy Co PLC is an independent energy company focused on natural gas and liquids production, transportation, marketing, and well retirement, predominantly located within the Appalachian and Central regions of the United States. The company acquires and manages gas and oil properties and certain associated midstream assets. Its operations are located throughout the neighboring states of Tennessee, Kentucky, Virginia, West Virginia, Ohio, Pennsylvania, Oklahoma, Texas, and Louisiana. The company has one reportable segment that produces and transports natural gas, natural gas liquids (NGLs), and oil in the United States.

Share on Social Networks: